Fortis Group Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1815183 WESTWOOD, NJ

Position in JNJ

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$182,350

-$323,884 QoQ

Shares Held

718

-65.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#4,514

of 4,664 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. JNJ ranks #6 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,471	$4,163,221
2	NVO	Novo Nordisk A S	72,916	$3,495,593
3	PFE	Pfizer Inc	62,653	$1,508,683
4	MRK	Merck & Co., Inc.	4,715	$605,877
5	AMGN	Amgen Inc	559	$202,424
6	JNJ	Johnson & Johnson This page	718	$182,350
7	GILD	Gilead Sciences, Inc.	246	$31,079
8	BMY	Bristol Myers Squibb Co	500	$28,810

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$182,350	718	-65.3%	Shares	Sole	2026-07-24
2026-03-31	$506,234	2,071	-78.4%	Shares	Sole	2026-05-08
2025-12-31	$1,980,510	9,570	+304.1%	Shares	Sole	2026-02-06
2025-09-30	$439,073	2,368	+161.9%	Shares	Sole	2025-11-07
2025-06-30	$138,086	904	+3.7%	Shares	Sole	2025-08-08
2025-03-31	$144,612	872	-65.5%	Shares	Sole	2025-05-02
2024-12-31	$365,888	2,530	0.0%	Shares	Sole	2025-01-31
2024-09-30	$410,011	2,530	+2.3%	Shares	Sole	2024-10-21
2024-06-30	$361,453	2,473	-17.6%	Shares	Sole	2024-07-30
2024-03-31	$474,727	3,001	-14.1%	Shares	Sole	2024-04-30
2023-12-31	$547,645	3,494	+39.9%	Shares	Sole	2024-03-04
2023-09-30	$389,060	2,498	+26.3%	Shares	Sole	2023-12-01
2023-06-30	$327,398	1,978	+31.7%	Shares	Sole	2023-07-18
2023-03-31	$232,810	1,502	-59.2%	Shares	Sole	2023-05-26
2020-09-30	$548,026	3,681	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.